DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Gemzar (Gemcitabine Hydrochloride) - Current Clinical Trials

 
 



Gemzar Related Clinical Trials

Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer [Completed]

Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine [Terminated]

Gemcitabine/Clofarabine/Busulfan and Allogeneic Transplantation for Aggressive Lymphomas [Recruiting]

PP-Gemcitabine & External Beam Radiation-Sarcomas [Completed]

A Two-Dimensional Dose-Finding Study of Ixazomib in Combination With Gemcitabine and Doxorubicin, Followed by a Phase II Extension to Assess the Efficacy of This Combination in Metastatic, Surgically Unresectable Urothelial Cancer [Recruiting]

Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers [Recruiting]

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer [Active, not recruiting]

Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors [Active, not recruiting]

Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer [Completed]

A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer [Completed]

Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy [Active, not recruiting]

Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma [Active, not recruiting]

Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Active, not recruiting]

HAI Abraxane With Gemcitabine and Bevacizumab [Completed]

Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer [Recruiting]

Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas [Terminated]

Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors [Completed]

PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine) [Recruiting]

Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer [Active, not recruiting]

A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin [Active, not recruiting]

Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma [Recruiting]

PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer [Recruiting]

A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas [Recruiting]

Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients [Active, not recruiting]

Gemcitabine Pharmacokinetics [Active, not recruiting]

Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors [Completed]

Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer. [Active, not recruiting]

Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection [Recruiting]

Huachansu & Gemcitabine in Pancreatic Cancer [Completed]

MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer [Active, not recruiting]

Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies [Completed]

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma [Active, not recruiting]

Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer [Completed]

Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer [Terminated]

Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies [Recruiting]

Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer [Recruiting]

ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors [Completed]

Pemetrexed Plus Gemcitabine in Renal Cell Cancer [Terminated]

Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Patients With Locally Advanced or Metastatic Pancreatic Cancer [Recruiting]

Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine [Recruiting]

GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors [Completed]

Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer [Terminated]

Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer [Recruiting]

Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer [Completed]

A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer [Completed]

Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer [Completed]

Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers [Recruiting]

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies [Completed]

Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB) [Completed]

Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma [Recruiting]

Gemcitabine and Dasatinib in Advanced Solid Tumors [Completed]

M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer [Recruiting]

Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC) [Withdrawn]

Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors [Completed]

Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies [Active, not recruiting]

Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Myeloma [Not yet recruiting]

Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer [Active, not recruiting]

Study of Low-Dose Radiation Therapy to the Whole Liver in Combination With Gemcitabine and Cisplatin in Intrahepatic Cholangiocarcinoma [Recruiting]

Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer [Recruiting]

Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection [Recruiting]

Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer [Completed]

Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients [Completed]

Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma [Active, not recruiting]

Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma [Recruiting]

Gemzar, Cisp, Sunitinib Urothelial Ca [Completed]

A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer [Completed]

Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas [Active, not recruiting]

Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors [Completed]

Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma [Terminated]

Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy [Active, not recruiting]

Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer [Recruiting]

Allogeneic Stem Cell Transplant for Chronic Lymphocytic Leukemia (CLL) [Recruiting]

Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Completed]

A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer [Completed]

CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer [Completed]

Selinexor, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Pancreatic Cancer [Recruiting]

Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer [Active, not recruiting]

Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer [Completed]

Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer [Recruiting]

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma [Completed]

Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma [Recruiting]

Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma [Active, not recruiting]

Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery [Recruiting]

Study of Gemcitabine and Abraxane for Pancreas Cancer [Recruiting]

Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC [Terminated]

Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor [Terminated]

Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Completed]

Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors [Completed]

The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer [Completed]

Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma [Active, not recruiting]

p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer [Recruiting]

A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer [Terminated]

Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma [Not yet recruiting]

Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-na�ve Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Completed]

ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed By Surgery [Recruiting]

Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015